R. Brownlee

Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide

J. Sinkovics, L. Baker, E. Frei, 1972, Cancer.

Clinical evaluation of toxic effects of cis-diamminedichloroplatinum (NSC-119875)--phase I clinical study.

J. Gutterman, K. McCredie, R. Talley, 1973, Cancer chemotherapy reports.

Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group study.

J. Saiki, V. Vaitkevicius, S. Jones, 1977, Cancer treatment reports.

Percutaneous transluminal angioplasty of tibial arteries for limb salvage

J. Killeen, R. Brownlee, Douglas C. Smith, 1992, CardioVascular and Interventional Radiology.

Adjuvant therapy in large bowel adenocarcinoma: long-term results of a Southwest Oncology Group Study.

P. Goodman, A. Cruz, V. Vaitkevicius, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of hexamethylmelamine for disseminated prostatic carcinoma.

M. al-Sarraf, A. Drelichman, R. Brownlee, 1981, Cancer clinical trials.

Chemotherapy of Metastatic Renal Adenocarcinoma with a Five- Drug Regimen*

R. Talley, R. Brownlee, N. Oberhauser, 1979 .

Phase II evaluation of chlorozotocin (NSC-178248) in advanced human cancer.

L. Baker, R. Talley, R. Fraile, 1981, European journal of cancer.

Response of advanced breast cancer to two dosage regiments of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).

V. Vaitkevicius, J. Bonnet, R. Talley, 1973, Cancer chemotherapy reports.

Preliminary trials with combination therapy of cyclophosphamide (NSC-26271), vincristine (NSC-67574), and 5-fluorouracil (NSC-19893).

P. Stott, J. Burrows, R. Talley, 1968, Cancer chemotherapy reports.

Chromomycin A3 for advanced breast cancer: a Southwest Oncology Group study.

B. Hoogstraten, F. Morrison, L. Baker, 1978, Cancer treatment reports.